Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Omegor is a premium brand of Omega-3 supplements owned by UGA Nutraceuticals, an Italian company founded in 2005. The company specializes in the research, development, and distribution of high-purity fish oil supplements that meet the highest international quality standards. Their products are consistently awarded the IFOS 5-star rating for purity, concentration, and freshness. Omegor's portfolio targets a wide range of health areas, including cardiovascular wellness, cognitive function, and maternal health. The company utilizes advanced molecular distillation processes to ensure their supplements are free from contaminants like heavy metals and PCBs. Omegor is recognized as a leader in the European nutraceutical market for its science-based approach to Omega-3 supplementation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Omegor.